Opinion|Videos|December 8, 2023

Elacestrant in Clinical Practice for Patients with ER+/HER2-Low Metastatic Breast Cancer

Dr. Paolo Tarantino offers expert guidance on optimizing outcomes for patients with ER+/HER2-low metastatic breast cancer.


Latest CME